NEW YORK (GenomeWeb News) — Twelve drug makers, including six top-10 pharma companies, signed up as “formation members” of what is being called the Severe Adverse Event Consortium, a far-reaching project to identify genetic biomarkers that might predict serious adverse events, according to a recent presentation made by its chairman.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.